Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.33 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.33 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL278674 | 0.84 | CYP3A4 (0.53) | CYP3A4TDP1ALDH1A1HPGDCASP3 | |
| SCHEMBL2807367 | 0.81 | CYP3A4 (0.49) | CYP3A4TDP1ALDH1A1HPGDCASP3 | |
| SCHEMBL17847479 | 0.79 | CYP3A4 (0.44) | CYP3A4TDP1ALDH1A1HPGDCASP3 | |
| SCHEMBL11613362 | 0.79 | PTGDR2 (0.42) | CYP3A4TDP1ALDH1A1HPGDMAPK1 | |
| SCHEMBL15822503 | 0.79 | PTGDR2 (0.42) | CYP3A4TDP1ALDH1A1HPGDCASP3 | |
| SCHEMBL17847449 | 0.79 | CYP3A4 (0.38) | CYP3A4TDP1ALDH1A1HPGDCASP3 | |
| SCHEMBL29687996 | 0.77 | CYP3A4 (0.48) | CYP3A4TDP1ALDH1A1HPGDCASP3 | |
| SCHEMBL185120 | 0.77 | CYP3A4 (0.48) | CYP3A4TDP1ALDH1A1HPGDCASP3 | |
| SCHEMBL11385650 | 0.77 | BACE1 (0.35) | ALDH1A1HPGDBACE1MAPK1PARP1 | |
| Methane SCHEMBL27501832 | 0.76 | CYP3A4 (0.47) | CYP3A4TDP1ALDH1A1HPGDCASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107223121-B | Wet stable holographic media | 科思创德国股份有限公司 | 2020-10-27 | — | — | CN | disclosed |
| EP-3233791-B1 | MOISTURE STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2020-08-12 | — | — | EP | disclosed |
| US-10329244-B2 | Moisture-stable holographic media | COVESTRO DEUTSCHLAND AG (DE) | 2019-06-25 | — | — | US | disclosed |
| US-20170362165-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2017-12-21 | — | — | US | disclosed |
| EP-3233791-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | Covestro Deutschland AG (DE) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016096641-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10329244-B2 | Moisture-stable holographic media | NEFM, MDM4, BHMT2 | CYP3A4 3992/4885TDP1 1478/4885ALDH1A1 3155/4885 |
| US-20170362165-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | NEFM, MDM4, BHMT2 | CYP3A4 3992/4885TDP1 1478/4885ALDH1A1 3155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.